Bacteriocins are relatively small antimicrobial peptides synthesized by the ribosomes of most known bacteria (e.g., Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria)
Although the influence of bacteriocins on animal intestinal microorganisms is well understood, bacteriocins have not yet been used in human medicine; hence the specific effects of bacteriocins on the human gut microbiota remain unknown.
The previous studies had mostly used in vitro fermentation systems where feces and bacteriocins were co-fermented to investigate the effects of bacteriocins on gut microbiota in vitro.
Bacteriocins are proteinaceous or peptidic toxins produced by bacteria to inhibit the growth of similar or closely related bacterial strain(s)
see also:
Antimicrobial peptides (AMPs) & Mode of Action (MoA)
Defense Systems / Defense Mechanisms
Lactobacillales / Lactic acid bacteria (LAB)
Microbial products
Pathogens / Pathobionts / Pathogenic Bacteria & Probiotics (living agents)
Pyocins